
Oropep 1.125 Injection
Marketer
Rishab Healthcare pvt. Ltd.
Salt Composition
Piperacillin (1000mg) + Tazobactum (125mg)
Overview Oropep 1.125 Injection
Oropep 1.125 Injection combines two antibiotics to combat diverse bacterial infections by eliminating microorganisms. Administered solely by healthcare professionals, self-injection is strictly prohibited. Dosage and frequency are determined by your physician based on your condition's severity; always adhere to the prescribed regimen. Common side effects may include nausea, vomiting, diarrhea, or rash, along with potential injection site reactions such as pain, swelling, or redness. Persistent or worsening side effects warrant immediate medical consultation. Prior to use, inform your doctor of any antibiotic allergies, liver, or kidney issues; dosage adjustments or alternative medications may be necessary. Under medical guidance, Oropep 1.125 Injection is generally considered safe for use during pregnancy and breastfeeding.
Primary Ingredients of Oropep 1.125 Injection
There is no text provided to rewrite.
Uses of Oropep 1.125 Injection
Infections caused by bacteria
Major Benefits of Oropep 1.125 Injection:
Administering this medication will be performed by your doctor or nurse; self-medication is strictly prohibited.
Common Side effects of Oropep 1.125 Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Oropep 1.125 Injection:
Administering this medication will be done by your doctor or nurse; please do not attempt self-medication.
How Oropep 1.125 Injection works:
Oropep 1.125 Injection combines Piperacillin, an antibiotic, with Tazobactum, a beta-lactamase inhibitor. Piperacillin's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Tazobactum counters bacterial resistance mechanisms, thereby boosting Piperacillin's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Oropep 1.125 Injection may be used concurrently with alcohol without adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Oropep 1.125 is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; clinical data in humans, however, remain scarce.
Breast feedingSAFE IF PRESCRIBED
Oropep 1.125 Injection poses no known breastfeeding risk. Research in humans indicates minimal drug transfer to breast milk, presenting no apparent infant harm.
DrivingCONSULT YOUR DOCTOR
Oropep 1.125 Injection's impact on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCAUTION
Individuals with impaired kidney function should exercise caution when using Oropep 1.125 Injection. Dosage modification for Oropep 1.125 Injection might be necessary. Medical advice is recommended.
LiverSAFE IF PRESCRIBED
The use of Oropep 1.125 Injection in individuals with hepatic impairment appears to pose minimal risk. Existing evidence indicates that dose modification for Oropep 1.125 Injection is likely unnecessary in such cases. However, physician consultation is recommended.
What if you forget to take Oropep 1.125 Injection :
Omiting a scheduled Oropep 1.125 Injection necessitates contacting your physician.
Facts to Know About Oropep 1.125 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
